---
title: "NeuroSim: Multi-disorder EEG Simulator for Personalized Pattern Injection and AI Modeling"
id: "biorxiv-5-neurosim-a-clinically-informed-multi-disorder-eeg-simulator-with-personalized"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-5-neurosim-a-clinically-informed-multi-disorder-eeg-simulator-with-personalized"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.19.767788v1?rss=1"
published_at: "2026-11-20T11:00:09.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# NeuroSim: Multi-disorder EEG Simulator for Personalized Pattern Injection and AI Modeling
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-5-neurosim-a-clinically-informed-multi-disorder-eeg-simulator-with-personalized
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.19.767788v1?rss=1)
- **Published At:** 2026-11-20T11:00:09.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- NeuroSim is an open-source EEG simulation framework designed to generate multichannel signals with controllable, disease-specific pattern injections across five disorders: **Alzheimer’s disease (AD)**, **Parkinson’s disease (PD)**, **schizophrenia (SCZ)**, **epilepsy (EPI)**, and **frontotemporal dementia (FTD)**. - The simulator combines a physiologically motivated baseline generator that produces band-limited rhythms, event-related potentials, artifacts, and hierarchical variability at subject and trial levels, enabling more realistic synthetic datasets. - Disease patterns are introduced via region- and severity-specific spectral modulation encoding established biomarkers such as posterior alpha suppression for **AD**, motor beta enhancement for **PD**, and spike-wave discharges for **EPI**. - An interactive interface lets users set montage, sampling rate, recording duration, artifact profiles, stimulus timing, affected regions, and severity; exported signals include reproducible metadata. - Simulated signals matched expected biomarker directionality under spectral, topographic, and multivariate statistical analyses reported by the authors. - A convolutional-attention classifier trained on NeuroSim data achieved 95.3–96.8% hold-out accuracy on simulated test sets; explainability analyses showed class-separable embeddings and attributions focused on pathophysiologically expected electrodes. - The study team validated compatibility with heterogeneous clinical recordings by applying the same analysis pipeline to the Temple University Hospital EEG Corpus; the source indicated compatibility but did not report numeric cross-dataset performance in the abstract. - In subject-level augmentation experiments, supplementing real EEG with NeuroSim samples improved classification accuracy from 91.6% to 94.5% for **AD** vs controls and from 90.9% to 94.0% for **PD** vs controls, outperforming conventional signal-level augmentation. - The preprint is released as open-source to support augmentation, benchmarking, and explainable AI in neurological diagnostics; the paper is a preprint and has not been peer-reviewed. - The abstract did not report specific training hyperparameters, dataset sizes, or full implementation details; readers should consult the full manuscript or code repository for those technical specifics.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=Lq5U0CY_ZJdTNRLmkVvspFOZZag_yB6yrvs7mygQ9Mo-1795172557.360044-1.2.1.1-LedkHI20CRYJDk14fqw9SgvdVzofN3Jx9oqiIx9vRi.fvomQ1D2XRVOrxlOT.Qf8) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.19.767788v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.19.767788v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # NeuroSim: a clinically informed multi-disorder EEG simulator with personalized pattern injection and AI-driven neurological modeling [ View ORCID Profile](http://orcid.org/0000-0001-5104-1177)Chayut Bunterngchit, Saba Aslam, Aamir Sattar, [ View ORCID Profile](http://orcid.org/0000-0001-5334-9001)Abdur Rasool, Yishan Wang doi: https://doi.org/10.64898/2026.11.19.767788 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Chayut Bunterngchit 1 King Mongkut's University of Technology North Bangkok; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chayut%2BBunterngchit%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Bunterngchit%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AChayut%2BBunterngchit%2B) * [ORCID record for Chayut Bunterngchit](http://orcid.org/0000-0001-5104-1177 "Open in new tab") Saba Aslam 2 Shenzhen Institutes of Advanced Technology; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Saba%2BAslam%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Aslam%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASaba%2BAslam%2B) Aamir Sattar 3 Shenzhen University; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Aamir%2BSattar%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Sattar%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAamir%2BSattar%2B) Abdur Rasool 4 University of Hawai'i at Manoa * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Abdur%2BRasool%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Rasool%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAbdur%2BRasool%2B) * [ORCID record for Abdur Rasool](http://orcid.org/0000-0001-5334-9001 "Open in new tab") * For correspondence: abdur@hawaii.edu Yishan Wang 2 Shenzhen Institutes of Advanced Technology; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yishan%2BWang%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Wang%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AYishan%2BWang%2B) * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.19.767788v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5979981/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.19.767788v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5979981/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.19.767788v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5979981/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.19.767788v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5979981/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Deep learning for electroencephalography (EEG) based neurodiagnostics is constrained by the limited availability of labeled clinical recordings. Datasets covering Alzheimer’s disease (AD), Parkinson’s disease (PD), schizophrenia (SCZ), epilepsy (EPI), and frontotemporal dementia (FTD) are scarce, demographically narrow, and heterogeneous across acquisition sites, while privacy requirements restrict data sharing. Existing EEG simulators typically address a single disorder or trade biological interpretability for statistical fidelity. This study presents NeuroSim, a simulation framework that generates synthetic multichannel EEG with user-controlled injection of disease-specific patterns across five disorders and multiple severity levels. A physiologically motivated baseline generator produces band-limited rhythms, event-related potentials, artifacts, and hierarchical subject-level and trial-level variability. Disease patterns are introduced through region-specific and severity-specific spectral modulation that encodes established biomarkers, including posterior alpha suppression in AD, motor beta enhancement in PD, and spike-wave discharges in EPI. An interactive interface exposes montage, sampling rate, duration, artifacts, stimuli, affected regions, and severity, and exports signals with reproducible metadata. The simulated signals reproduced the expected biomarker directionality under spectral, topographic, and multivariate statistical analysis. A convolutional-attention classifier trained on simulated data reached 95.3 to 96.8 percent hold-out accuracy, and post hoc explainability analyses produced class-separable embeddings with attributions concentrated on pathophysiologically expected electrodes. Application of the analysis pipeline to recordings from the Temple University Hospital EEG Corpus confirmed compatibility with heterogeneous clinical data. In subject-level augmentation experiments on real clinical EEG, supplementing real training data with NeuroSim samples increased classification accuracy from 91.6 to 94.5 percent for AD versus healthy controls and from 90.9 to 94.0 percent for PD versus healthy controls, exceeding the improvement obtained with conventional signal-level augmentation. NeuroSim is released as open-source software to support augmentation, benchmarking, and explainable artificial intelligence in neurological diagnostics. ### Competing Interest Statement The authors have declared no competing interest. Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.19.767788v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.16.767202v1 "The genetic architecture of lipoprotein\(a\): simplicity, complexity, and mutability") Posted November 20, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.19.767788v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/20/2026.11.19.767788.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) NeuroSim: a clinically informed multi-disorder EEG simulator with personalized pattern injection and AI-driven neurological modeling Chayut Bunterngchit, Saba Aslam, Aamir Sattar, Abdur Rasool, Yishan Wang bioRxiv 2026.11.19.767788; doi: https://doi.org/10.64898/2026.11.19.767788 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767788v1%26text%3DNeuroSim%253A%2520a%2520clinically%2520informed%2520multi-disorder%2520EEG%2520simulator%2520with%2520personalized%2520pattern%2520injection%2520and%2520AI-driven%2520neurological%2520modeling "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767788v1%26t%3DNeuroSim%253A%2520a%2520clinically%2520informed%2520multi-disorder%2520EEG%2520simulator%2520with%2520personalized%2520pattern%2520injection%2520and%2520AI-driven%2520neurological%2520modeling "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767788v1%26title%3DNeuroSim%253A%2520a%2520clinically%2520informed%2520multi-disorder%2520EEG%2520simulator%2520with%2520personalized%2520pattern%2520injection%2520and%2520AI-driven%2520neurological%2520modeling%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767788v1%26title%3DNeuroSim%253A%2520a%2520clinically%2520informed%2520multi-disorder%2520EEG%2520simulator%2520with%2520personalized%2520pattern%2520injection%2520and%2520AI-driven%2520neurological%2520modeling "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.19.767788) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.19.767788v1&count=horizontal&via=&text=NeuroSim%3A%20a%20clinically%20informed%20multi-disorder%20EEG%20simulator%20with%20personalized%20pattern%20injection%20and%20AI-driven%20neurological%20modeling&counturl=www.biorxiv.org/content/10.64898/2026.11.19.767788v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineer
## Related Clinical Research

- [EEG-derived indices classify sporadic Creutzfeldt-Jakob disease from Alzheimer’s and healthy aging](https://medichelpline.com/clinical-feed/plos-one-17-classification-of-sporadic-creutzfeldt-jakob-disease-based-on-resting-state.md)
- [High-resolution map of the basal ganglia reveals cell types tied to Parkinson’s and schizophrenia](https://medichelpline.com/clinical-feed/stat-news-1-stat-scientists-debut-map-of-basal-ganglia-a-key-brain-region-involved-in-an.md)
- [Theta–gamma phase coupling predicts item-specific neural and perceptual biases in speech categoriz](https://medichelpline.com/clinical-feed/biorxiv-6-item-specific-clustering-of-high-gamma-band-activity-on-theta-phase-during.md)
- [Safety of Stroboscopic Light Stimulation: Observational Evidence and Guidelines](https://medichelpline.com/clinical-feed/plos-one-23-stroboscopic-light-stimulation-safety-within-and-beyond-laboratory-settings.md)
- [Neuron type–specific Bassoon loss in mice links interneuron deficits to schizophrenia-like behavio](https://medichelpline.com/clinical-feed/biorxiv-8-dissection-of-neuropsychiatric-relevant-behavioral-and-structural-phenotypes.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.